1
|
Lopez-Santana G, De Rosis A, Grant S, Venkateswaran R, Keshmiri A. Enhancing the implantation of mechanical circulatory support devices using computational simulations. Front Bioeng Biotechnol 2024; 12:1279268. [PMID: 38737533 PMCID: PMC11084291 DOI: 10.3389/fbioe.2024.1279268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2023] [Accepted: 04/08/2024] [Indexed: 05/14/2024] Open
Abstract
Introduction: Patients with end-stage heart failure (HF) may need mechanical circulatory support such as a left ventricular assist device (LVAD). However, there are a range of complications associated with LVAD including aortic regurgitation (AR) and thrombus formation. This study assesses whether the risk of developing aortic conditions can be minimised by optimising LVAD implantation technique. Methods: In this work, we evaluate the aortic flow patterns produced under different geometrical parameters for the anastomosis of the outflow graft (OG) to the aorta using computational fluid dynamics (CFD). A three-dimensional aortic model is created and the HeartMate III OG positioning is simulated by modifying (i) the distance from the anatomic ventriculo-arterial junction (AVJ) to the OG, (ii) the cardinal position around the aorta, and (iii) the angle between the aorta and the OG. The continuous LVAD flow and the remnant native cardiac cycle are used as inlet boundaries and the three-element Windkessel model is applied at the pressure outlets. Results: The analysis quantifies the impact of OG positioning on different haemodynamic parameters, including velocity, wall shear stress (WSS), pressure, vorticity and turbulent kinetic energy (TKE). We find that WSS on the aortic root (AoR) is around two times lower when the OG is attached to the coronal side of the aorta using an angle of 45° ± 10° at a distance of 55 mm. Discussion: The results show that the OG placement may significantly influence the haemodynamic patterns, demonstrating the potential application of CFD for optimising OG positioning to minimise the risk of cardiovascular complications after LVAD implantation.
Collapse
Affiliation(s)
- Gabriela Lopez-Santana
- School of Engineering, The University of Manchester, Manchester, United Kingdom
- Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Wythenshawe Hospital, Manchester, United Kingdom
| | - Alessandro De Rosis
- School of Engineering, The University of Manchester, Manchester, United Kingdom
| | - Stuart Grant
- Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
- Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom
| | - Rajamiyer Venkateswaran
- Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Wythenshawe Hospital, Manchester, United Kingdom
- Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom
| | - Amir Keshmiri
- School of Engineering, The University of Manchester, Manchester, United Kingdom
- Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
| |
Collapse
|
2
|
Załucka L, Świerżyńska E, Orczykowski M, Dutkowski K, Szymański J, Kuriata J, Dąbrowski R, Kołsut P, Szumowski Ł, Sterliński M. Ventricular Arrhythmias in Left Ventricular Assist Device Patients-Current Diagnostic and Therapeutic Considerations. SENSORS (BASEL, SWITZERLAND) 2024; 24:1124. [PMID: 38400282 PMCID: PMC10893394 DOI: 10.3390/s24041124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/14/2023] [Revised: 01/18/2024] [Accepted: 01/28/2024] [Indexed: 02/25/2024]
Abstract
Left ventricular assist devices (LVAD) are used in the treatment of advanced left ventricular heart failure. LVAD can serve as a bridge to orthotopic heart transplantation or as a destination therapy in cases where orthotopic heart transplantation is contraindicated. Ventricular arrhythmias are frequently observed in patients with LVAD. This problem is further compounded as a result of diagnostic difficulties arising from presently available electrocardiographic methods. Due to artifacts from LVAD-generated electromagnetic fields, it can be challenging to assess the origin of arrhythmias in standard ECG tracings. In this article, we will review and discuss common mechanisms, diagnostics methods, and therapeutic strategies for ventricular arrhythmia treatment, as well as numerous problems we face in LVAD implant patients.
Collapse
Affiliation(s)
- Laura Załucka
- Department of Cardiac Surgery and Transplantology, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland; (L.Z.); (J.S.); (P.K.)
| | - Ewa Świerżyńska
- 1st Department of Arrhythmia, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland
- Doctoral School, Medical University of Warsaw, 61 Zwirki I Wigury Street, 02-091 Warsaw, Poland
| | - Michał Orczykowski
- 1st Department of Arrhythmia, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland
| | - Krzysztof Dutkowski
- Department of Cardiac Surgery and Transplantology, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland; (L.Z.); (J.S.); (P.K.)
| | - Jarosław Szymański
- Department of Cardiac Surgery and Transplantology, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland; (L.Z.); (J.S.); (P.K.)
| | - Jarosław Kuriata
- Department of Cardiac Surgery and Transplantology, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland; (L.Z.); (J.S.); (P.K.)
| | - Rafał Dąbrowski
- Department of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland
| | - Piotr Kołsut
- Department of Cardiac Surgery and Transplantology, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland; (L.Z.); (J.S.); (P.K.)
| | - Łukasz Szumowski
- 1st Department of Arrhythmia, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland
| | - Maciej Sterliński
- 1st Department of Arrhythmia, National Institute of Cardiology, 42 Alpejska Street, 04-628 Warsaw, Poland
| |
Collapse
|
3
|
Nisbet AI, Ahmadian D, Vedantham S, Chiang JA. An unusual artifact observed on screening mammography in a patient with an LVAD. J Appl Clin Med Phys 2024; 25:e14255. [PMID: 38179858 PMCID: PMC10860483 DOI: 10.1002/acm2.14255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Revised: 12/06/2023] [Accepted: 12/12/2023] [Indexed: 01/06/2024] Open
Abstract
PURPOSE Screening mammography and digital breast tomosynthesis consist of high-resolution x-ray images to identify findings that are potentially indicative of breast cancer, enabling early detection and reduction of breast cancer mortality. Imaging artifacts can occasionally occur, sometimes due to patient-related medical devices. Because of continuous evolution of new technologies, there is potential for novel artifacts to be encountered. In this technical note, we report an unusual artifact in the screening mammogram of a patient with an Abbott HeartMate 3 left ventricular assist device (LVAD). METHODS A 72-year-old patient with a HeartMate 3 LVAD presented to our breast imaging facility for a standard screening exam with digital breast tomosynthesis (Selenia Dimensions, Hologic Inc., Bedford, MA) and synthetic 2D images (C-view, Hologic Inc., Bedford, MA). RESULTS Linear artifacts oriented in the anteroposterior dimension demonstrating a spatial periodicity of ∼1.4 mm were seen on all left breast images, whereas concurrent right breast images did not demonstrate any artifacts. Repeat attempts using two identical digital breast tomosynthesis units demonstrated the same artifacts. No other exam at our imaging center that day demonstrated any such artifacts. Mammogram exams performed on this patient prior to her LVAD placement did not exhibit any similar artifacts. CONCLUSION Findings support the patient's LVAD as the underlying source of linear artifacts observed on left breast images, particularly given the proximity of the LVAD to the left breast. With the number of patients receiving LVAD placement on the rise, as well as increasing median survival rates status post LVAD implantation, recognition of this LVAD related artifact on mammography may be important.
Collapse
Affiliation(s)
- Audrey I. Nisbet
- Department of Medical ImagingUniversity of ArizonaTucsonArizonaUSA
| | - David Ahmadian
- College of MedicineUniversity of ArizonaTucsonArizonaUSA
| | | | | |
Collapse
|
4
|
Zaloznik Djordjevic J, Özkan T, Göncz E, Ksela J, Möckel M, Strnad M. Common Complications and Cardiopulmonary Resuscitation in Patients with Left Ventricular Assist Devices: A Narrative Review. MEDICINA (KAUNAS, LITHUANIA) 2023; 59:1981. [PMID: 38004030 PMCID: PMC10672734 DOI: 10.3390/medicina59111981] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/12/2023] [Revised: 10/28/2023] [Accepted: 11/08/2023] [Indexed: 11/26/2023]
Abstract
Heart failure remains a major global burden regarding patients' morbidity and mortality and health system organization, logistics, and costs. Despite continual advances in pharmacological and resynchronization device therapy, it is currently well accepted that heart transplantation and mechanical circulatory support represent a cornerstone in the management of advanced forms of this disease, with the latter becoming an increasingly accepted treatment modality due to the ongoing shortage of available donor hearts in an ever-increasing pool of patients. Mechanical circulatory support strategies have seen tremendous advances in recent years, especially in terms of pump technology improvements, indication for use, surgical techniques for device implantation, exchange and explantation, and postoperative patient management, but not in the field of treatment of critically ill patients and those undergoing cardiac arrest. This contemporary review aims to summarize the collected knowledge of this topic with an emphasis on complications in patients with left ventricular assist devices, their treatment, and establishing a clear-cut algorithm and the latest recommendations regarding out-of-hospital or emergency department management of cardiac arrest in this patient population.
Collapse
Affiliation(s)
| | - Timur Özkan
- Department of Emergency and Acute Medicine, Charité—Universitätsmedizin Berlin, 10117 Berlin, Germany
| | - Eva Göncz
- Department of Emergency and Acute Medicine, Charité—Universitätsmedizin Berlin, 10117 Berlin, Germany
| | - Jus Ksela
- Department of Cardiovascular Surgery, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia
| | - Martin Möckel
- Department of Emergency and Acute Medicine, Charité—Universitätsmedizin Berlin, 10117 Berlin, Germany
| | - Matej Strnad
- Department of Emergency Medicine, University Medical Centre Maribor, 2000 Maribor, Slovenia
| |
Collapse
|
5
|
Tasos E, Sequeira J, Lincoln P, Pettit S, Bhagra S. Diagnostic quality electrocardiogram from a HeartMate 3 supported patient using a smartphone-based recording device. Int J Artif Organs 2023; 46:589-591. [PMID: 37278015 DOI: 10.1177/03913988231178042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Patients with implantable left ventricular assist devices (LVAD) are at risk of ventricular arrhythmias but these may be hemodynamically tolerated. An electrocardiogram (ECG) is essential to determine whether an LVAD-supported patient is experiencing a ventricular arrhythmia. Access to 12 lead ECG is predominantly in healthcare facilities. Implantable LVAD also cause significant electromagnetic interference leading to artefacts on ECG. We report a patient on Heartmate 3 LVAD with a diagnostic quality 6 lead ECG obtained with an AliveCor device during an episode of sustained palpitations. The AliveCor device may be used for remote identification of ventricular arrhythmias in LVAD patients.
Collapse
Affiliation(s)
- Emmanuel Tasos
- Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK
| | - Joao Sequeira
- Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK
| | - Paul Lincoln
- Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK
| | - Stephen Pettit
- Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK
| | - Sai Bhagra
- Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK
| |
Collapse
|
6
|
Khetarpal BK, Javaid A, Lee JZ, Kusumoto F, Mulpuru SK, Sorajja D, Cha Y, Srivathsan K. Subcutaneous implantable cardioverter-defibrillator noise following left ventricular assist device implantation. J Arrhythm 2023; 39:198-206. [PMID: 37021015 PMCID: PMC10068942 DOI: 10.1002/joa3.12826] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2022] [Revised: 01/14/2023] [Accepted: 01/27/2023] [Indexed: 04/05/2023] Open
Abstract
Background The incidence and impact of noise in a subcutaneous implantable cardioverter defibrillator (S-ICD) after left ventricular assist device (LVAD) implantation is not well established. Methods We performed a retrospective study of patients implanted with LVAD and with a pre-existing S-ICD between January 2005 and December 2020 at the three Mayo Clinic centers (Minnesota, Arizona, and Florida). Results Of the 908 LVAD patients, a pre-existing S-ICD was present in 9 patients (mean age 49.1 ± 13.7 years, 66.7% males), 100% with Boston Scientific third-generation EMBLEM MRI S-ICD, 11% with HeartMate II (HM II), 44% with HeartMate 3 (HM 3), and 44% with HeartWare (HW) LVAD. The incidence of noise from LVAD-related electromagnetic interference (EMI) was 33% and was only seen with HM 3 LVAD. Multiple measures attempted to resolve noise, including using alternative S-ICD sensing vector, adjusting S-ICD time zone, and increasing LVAD pump speed, were unsuccessful, necessitating S-ICD device therapies to be turned off permanently. Conclusions The incidence of LVAD-related S-ICD noise is high in patients with concomitant LVAD and S-ICD with significant impact on device function. As conservative management failed to resolve the EMI, the S-ICDs had to be programmed off to avoid inappropriate shocks. This study highlights the importance of awareness of LVAD-SICD device interference and the need to improve S-ICD detection algorithms to eliminate noise.
Collapse
Affiliation(s)
| | - Awad Javaid
- Cardiovascular DepartmentKirk Kerkorian School of Medicine at UNLVNevadaUSA
| | - Justin Z. Lee
- Cardiovascular DepartmentMayo ClinicPhoenixArizonaUSA
| | - Fred Kusumoto
- Cardiovascular DepartmentMayo ClinicJacksonvilleFloridaUSA
| | | | - Dan Sorajja
- Cardiovascular DepartmentMayo ClinicPhoenixArizonaUSA
| | - Yong‐Mei Cha
- Cardiovascular DepartmentMayo ClinicRochesterMinnesotaUSA
| | | |
Collapse
|
7
|
Suppression of electromagnetic interference in electroretinography from a patient with an implanted left ventricular assist device (LVAD). Doc Ophthalmol 2022; 144:137-145. [PMID: 35247110 DOI: 10.1007/s10633-022-09865-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2021] [Accepted: 01/28/2022] [Indexed: 11/03/2022]
Abstract
PURPOSE A left ventricular assist device (LVAD) is an implantable cardiac pump that uses a magnetically-levitating rotor to pump blood into circulation for patients with congestive heart failure. The continuous high-frequency motion of the pump can cause significant interference in electroretinography (ERG) recordings. We evaluate filtering methods to improve ERG quality in the presence of LVAD interference. METHODS A patient with an implanted LVAD was referred to our clinic for ERG testing on suspicion of a retinal dystrophy. Full-field ERG (ffERG) and pattern ERG (pERG) were performed according to ISCEV standards. Recordings were acquired once in full-bandwidth mode and again in low-bandwidth mode. Digital low-pass and band-stop filtering were performed to mitigate ERG interference. Post-processing was also evaluated in a control subject with no implanted device. RESULTS High-frequency interference was present in all ERG recordings and corresponded to the speed settings of the pump. When applied in post-processing, both low-pass and band-stop filters suppressed the interference and presented readable ERGs without affecting peak times or amplitudes. By contrast, when recording in low-bandwidth mode, the filter drop-off was not steep enough to completely remove the interference and peak delays were introduced that could not be readily corrected. CONCLUSIONS LVAD interference in ERG waveforms can be successfully removed using simple digital filters. If post hoc data processing capabilities are unavailable, a large amount of interference can be removed by narrowing the acquisition bandwidth and averaging additional repeats of each stimulus response.
Collapse
|
8
|
Li G, Tan Z, Xu W, Xu F, Wang L, Chen J, Wu K. A particle swarm optimization improved BP neural network intelligent model for electrocardiogram classification. BMC Med Inform Decis Mak 2021; 21:99. [PMID: 34330266 PMCID: PMC8322832 DOI: 10.1186/s12911-021-01453-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2021] [Accepted: 02/22/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND As proven to reflect the work state of heart and physiological situation objectively, electrocardiogram (ECG) is widely used in the assessment of human health, especially the diagnosis of heart disease. The accuracy and reliability of abnormal ECG (AECG) decision depend to a large extent on the feature extraction. However, it is often uneasy or even impossible to obtain accurate features, as the detection process of ECG is easily disturbed by the external environment. And AECG got many species and great variation. What's more, the ECG result obtained after a long time past, which can not reach the purpose of early warning or real-time disease diagnosis. Therefore, developing an intelligent classification model with an accurate feature extraction method to identify AECG is of quite significance. This study aimed to explore an accurate feature extraction method of ECG and establish a suitable model for identifying AECG and the diagnosis of heart disease. METHODS In this research, the wavelet combined with four operations and adaptive threshold methods were applied to filter the ECG and extract its feature waves first. Then, a BP neural network (BPNN) intelligent model and a particle swarm optimization (PSO) improved BPNN (PSO-BPNN) intelligent model based on MIT-BIH open database was established to identify ECG. To reduce the complexity of the model, the principal component analysis (PCA) was used to minimize the feature dimension. RESULTS Wavelet transforms combined four operations and adaptive threshold methods were capable of ECG filtering and feature extraction. PCA can significantly deduce the modeling feature dimension to minimize the complexity and save classification time. The PSO-BPNN intelligent model was suitable for identifying five types of ECG and showed better effects while comparing it with the BPNN model. CONCLUSION In summary, it was further concluded that the PSO-BPNN intelligent model would be a suitable way to identify AECG and provide a tool for the diagnosis of heart disease.
Collapse
Affiliation(s)
- Guixiang Li
- National Engineering Research Center for Healthcare Devices, Guangdong Key Lab of Medical Electronic Instruments and Polymer Material Products, Guangdong Institute of Medical Instruments, Institute of Medicine and Health, Guangdong Academy of Sciences, Guangzhou, 510500, China.,Guangdong Engineering Technology Research Center for Diagnosis and Rehabilitation of Dementia, Guangzhou, 510500, China
| | - Zhongwei Tan
- National Engineering Research Center for Healthcare Devices, Guangdong Key Lab of Medical Electronic Instruments and Polymer Material Products, Guangdong Institute of Medical Instruments, Institute of Medicine and Health, Guangdong Academy of Sciences, Guangzhou, 510500, China
| | - Weikang Xu
- National Engineering Research Center for Healthcare Devices, Guangdong Key Lab of Medical Electronic Instruments and Polymer Material Products, Guangdong Institute of Medical Instruments, Institute of Medicine and Health, Guangdong Academy of Sciences, Guangzhou, 510500, China
| | - Fei Xu
- National Engineering Research Center for Healthcare Devices, Guangdong Key Lab of Medical Electronic Instruments and Polymer Material Products, Guangdong Institute of Medical Instruments, Institute of Medicine and Health, Guangdong Academy of Sciences, Guangzhou, 510500, China
| | - Lei Wang
- Department of Artificial Intelligence, College of Information and Communication Engineering, Hainan University, Haikou, 570228, China.
| | - Jun Chen
- National Engineering Research Center for Healthcare Devices, Guangdong Key Lab of Medical Electronic Instruments and Polymer Material Products, Guangdong Institute of Medical Instruments, Institute of Medicine and Health, Guangdong Academy of Sciences, Guangzhou, 510500, China. .,Guangdong Engineering Technology Research Center for Diagnosis and Rehabilitation of Dementia, Guangzhou, 510500, China.
| | - Kai Wu
- Department of Biomedical Engineering, School of Material Science and Engineering, South China University of Technology, Guangzhou, 510006, China. .,Guangdong Engineering Technology Research Center for Diagnosis and Rehabilitation of Dementia, Guangzhou, 510500, China. .,Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, 510370, China. .,The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou Huiai Hospital, Guangzhou, 510370, China. .,National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Guangzhou, 510006, China. .,Key Laboratory of Biomedical Engineering of Guangdong Province, South China University of Technology, Guangzhou, 510006, China. .,Department of Nuclear Medicine and Radiology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, 980-8575, Japan.
| |
Collapse
|
9
|
Li A, Atteya G, Vullaganti S, Mitra R. Surface mapping demonstrates compatibility of implantable loop monitor with a continuous-flow left ventricular assist device. ESC Heart Fail 2021; 8:3392-3396. [PMID: 34042310 PMCID: PMC8318441 DOI: 10.1002/ehf2.13343] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2021] [Revised: 03/02/2021] [Accepted: 03/24/2021] [Indexed: 12/13/2022] Open
Abstract
Syncope in patients with continuous‐flow left ventricular assist device may be associated with arrhythmia and difficult to determine without an implantable cardioverter defibrillator. We present a patient with continuous‐flow left ventricular assist device, no implantable cardioverter defibrillator, and recurrent syncope. An implantable loop recorder was successfully implanted with surface mapping without noise interference.
Collapse
Affiliation(s)
- Angela Li
- Department of Cardiology, Sandra Atlas Bass Heart Hospital, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 300 Community Drive, 1 Cohen, Manhasset, NY, 11030, USA
| | - Gourg Atteya
- Department of Cardiology, Sandra Atlas Bass Heart Hospital, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 300 Community Drive, 1 Cohen, Manhasset, NY, 11030, USA
| | - Sirish Vullaganti
- Department of Cardiology, Sandra Atlas Bass Heart Hospital, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 300 Community Drive, 1 Cohen, Manhasset, NY, 11030, USA
| | - Ramanak Mitra
- Department of Cardiology, Sandra Atlas Bass Heart Hospital, North Shore University Hospital, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, 300 Community Drive, 1 Cohen, Manhasset, NY, 11030, USA
| |
Collapse
|
10
|
Loring Z, Sen S, Black-Maier E, Atwater BD, Russell SD, DeVore AD, Piccini JP. Reducing ECG Artifact From Left Ventricular Assist Device Electromagnetic Interference. J Am Heart Assoc 2020; 9:e017563. [PMID: 32787630 PMCID: PMC7660795 DOI: 10.1161/jaha.120.017563] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background Left ventricular assist devices (LVADs) generate electromagnetic interference that causes high-frequency noise artifacts on 12-lead ECGs. We describe the causes of this interference and potential solutions to aid ECG interpretation in patients with LVAD. Methods and Results Waveform data from ECGs performed before and after LVAD implantation were passed through a fast Fourier transform to identify LVAD-related changes in the spectral profile. ECGs recorded in 9 patients with HeartMate II, HeartMate 3, and HeartWare LVADs were analyzed to identify the LVAD model-specific spectral patterns. Waveform data were then passed through digital low-pass and bandstop filters and redisplayed to evaluate the effect of filtering on LVAD-related electromagnetic interference. The spectral profile of patients with HeartMate II and HeartMate 3 LVADs demonstrated a prominent signal at the device-specific frequency of impeller rotation. In patients with the HeartMate 3 LVAD, 2 additional peaks were observed at the frequencies equivalent to the LVAD's artificial pulsatility rotational speeds. Patients with HeartWare devices demonstrated a prominent signal peak at a frequency equal to double their LVAD's set rotational speed. Applying a low-pass filter to a value below the observed frequency peak from the LVAD significantly improved the waveform tracing and quality of the ECG. Applying a speed-specific bandstop filter to remove the observed LVAD frequency peak also improved the clarity of the ECG without compromising physiological high-frequency signal components. Conclusions LVADs create impeller rotational speed-specific electromagnetic interference that can be ameliorated by application of low-pass or bandstop filters to improve ECG clarity.
Collapse
Affiliation(s)
- Zak Loring
- Duke Clinical Research Institute Durham NC.,Division of Cardiology Duke University Medical Center Durham NC
| | - Sounok Sen
- Division of Cardiology Duke University Medical Center Durham NC
| | - Eric Black-Maier
- Duke Clinical Research Institute Durham NC.,Division of Cardiology Duke University Medical Center Durham NC
| | - Brett D Atwater
- Division of Cardiology Duke University Medical Center Durham NC
| | | | - Adam D DeVore
- Duke Clinical Research Institute Durham NC.,Division of Cardiology Duke University Medical Center Durham NC
| | - Jonathan P Piccini
- Duke Clinical Research Institute Durham NC.,Division of Cardiology Duke University Medical Center Durham NC
| |
Collapse
|